Sep 02, 2025
Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results
Jul 23, 2025
Boston Scientific announces results for second quarter 2025
Jul 07, 2025
Boston Scientific receives FDA approval for expanded labeling of FARAPULSE(TM) Pulsed Field Ablation System
May 01, 2025
Boston Scientific announces upcoming investor conference schedule
Apr 24, 2025
Second phase of ADVANTAGE AF study of FARAPULSE(TM) Pulsed Field Ablation System meets primary safety and efficacy endpoints
Apr 23, 2025
Boston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed Brennan
Apr 01, 2025
Boston Scientific announces conference call discussing first quarter 2025 results
Mar 03, 2025
Boston Scientific announces agreement to acquire SoniVie Ltd.
Feb 26, 2025
Boston Scientific announces completion of EUR1.5 billion offering of senior notes
Feb 21, 2025
Boston Scientific announces pricing of EUR1.5 billion of senior notes
Feb 19, 2025
Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference
Feb 05, 2025
Boston Scientific announces results for fourth quarter and full year 2024
Jan 16, 2025
Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation
Nov 16, 2024
Boston Scientific WATCHMAN FLX(TM) Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial
Nov 05, 2024
Boston Scientific to Participate in the 2024 UBS Global Healthcare Conference
Nov 04, 2024
Boston Scientific Announces Agreement to Acquire Cortex, Inc.
Oct 30, 2024
ACURATE neo2(TM) Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024
Oct 23, 2024
Boston Scientific Announces Results for Third Quarter 2024
Sep 17, 2024
Boston Scientific Closes Acquisition of Silk Road Medical, Inc.
Sep 17, 2024
Boston Scientific Receives FDA Approval for Expanded Indication of INGEVITY(TM)+ Pacing Leads to Include Conduction System Pacing of the Left Bundle Branch Area